It is essential to study the mechanism of Ggpps-regulated prenylation within the mevalonate pathway during spermatogenesis to determine effective drug targets and to avoid the side effects of dyslipidemia treatment and to treat primary male sterility. This evidence concerns the gene GGPS1 and metabolic syndrome.